EPOCH BIODESIGN LTD
No Analysis Available
Get instant AI-powered insights about this company's financial health, risks, and trends.
Order Analysis - £10- Legal registered address
- 10 Finsbury Square London England EC2A 1AJ Copied!
Company received £139,618 of state aid to support it through COVID-19 more details
Latest financial results as of 7 September 2025- Cash in bank
- £2.04m
- Current assets
- £3.16m
- Current creditors
- £311.06k
- Shareholders funds
- £10.96m
View full financial accounts- Cash in bank
- £2.04m
- Current assets
- £3.16m
- Current creditors
- £311.06k
- Shareholders funds
- £10.96m
- Company number
- 11824812 Copied!
Accounts
Latest annual accounts were to 31 March 2024
Next annual accounts are due by 31 December 2025
Company financial year end is on 31 March 2026
Confirmation statement
Latest confirmation statement statement dated 12 February 2025
Next statement due by 26 February 2026
Nature of business (SIC)
72110 - Research and experimental development on biotechnology
Previous company names
| Name | Date previous name changed |
|---|---|
| MELLIZYME BIOTECHNOLOGY LIMITED | 15 February 2023 |
Latest company documents
| Date | Description |
|---|---|
| 18/03/2518 March 2025 | Statement of capital following an allotment of shares on 2025-03-06 |
| 06/03/256 March 2025 | Confirmation statement made on 2025-02-12 with updates |
| 26/02/2526 February 2025 | Cessation of Jacob Leon Nathan as a person with significant control on 2024-11-13 |
| 26/02/2526 February 2025 | Notification of a person with significant control statement |
| 25/02/2525 February 2025 | Statement of capital following an allotment of shares on 2025-01-27 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company